Hemostasis and thrombosis in patients with liver disease: The ups and downs

Journal of Hepatology

Volumn 53, Issue 2, 2010, Pages 362-371

  Lisman, Ton ^a,b   Caldwell, Stephen H ^c   Burroughs, Andrew K ^d   Northup, Patrick G ^c   Senzolo, Marco ^e   Stravitz, R Todd ^f   Tripodi, Armando ^g   Trotter, James F ^h   Valla, Dominique Charles ⁱ   Porte, Robert J ^a  

^a Section Hepatobiliairy Surgery and Liver Transplantation   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF VIRGINIA   (United States)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^f VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^g FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^h BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

ⁱ ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Bleeding; Hemostasis; Liver disease; Non alcoholic steatohepatitis; Platelet; Thrombin; Thrombosis

Indexed keywords

ANTIBIOTIC AGENT; ANTIVITAMIN K; DESMOPRESSIN; LOW MOLECULAR WEIGHT HEPARIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOCYTE CONCENTRATE;

ARTERY THROMBOSIS; BLEEDING; BLEEDING TENDENCY; BLOOD CLOTTING TEST; CHRONIC LIVER DISEASE; CONFERENCE PAPER; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; HYPOCOAGULABILITY; LIVER DISEASE; LIVER FAILURE; NONALCOHOLIC FATTY LIVER; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; THROMBOSIS; VEIN THROMBOSIS; COMPLICATION; HEMORRHAGE; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

HEMORRHAGE; HEMOSTASIS; HUMANS; LIVER DISEASES; RISK FACTORS; THROMBOSIS;

EID: 77955018448     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.01.042     Document Type: Conference Paper

References (127)

1. T. Lisman, F.W.G. Leebeek, and P.G. de Groot Haemostatic abnormalities in patients with liver disease J Hepatol 37 2002 280 287
2. T. Lisman, S.H. Caldwell, F.W. Leebeek, and R.J. Porte Is chronic liver disease associated with a bleeding diathesis? J Thromb Haemost 4 2006 2059 2060
3. A. Tripodi, and P.M. Mannucci Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research J Hepatol 46 2007 727 733
4. P.G. Northup, V. Sundaram, M.B. Fallon, K.R. Reddy, R.A. Balogun, and A.J. Sanyal Hypercoagulation and thrombophilia in liver disease J Thromb Haemost 6 2008 2 9
5. T. Lisman, and F.W. Leebeek Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment Dig Surg 24 2007 250 258
6. S.H. Caldwell, M. Hoffman, T. Lisman, B.G. Macik, P.G. Northup, and K.R. Reddy Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management Hepatology 44 2006 1039 1046
7. T. Lisman, T.N. Bongers, J. Adelmeijer, H.L. Janssen, M.P. de Maat, and P.G. de Groot Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity Hepatology 44 2006 53 61
8. P.M. Mannucci, M.T. Canciani, I. Forza, F. Lussana, A. Lattuada, and E. Rossi Changes in health and disease of the metalloprotease that cleaves von Willebrand factor Blood 98 2001 2730 2735
9. S. Reitsma, D.W. Slaaf, H. Vink, M.A. van Zandvoort, and M.G. oude Egbrink The endothelial glycocalyx: composition, functions, and visualization Pflugers Arch 454 2007 345 359
10. M. Senzolo, E. Cholongitas, U. Thalheimer, A. Riddell, S. Agarwal, and S. Mallett Heparin-like effect in liver disease and liver transplantation Clin Liver Dis 13 2009 43 53
11. A. Tripodi, F. Salerno, V. Chantarangkul, M. Clerici, M. Cazzaniga, and M. Primignani Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests Hepatology 41 2005 553 558
12. A. Tripodi, M. Primignani, V. Chantarangkul, A. Dell'Era, M. Clerici, and R. de Franchis An imbalance of pro- vs. anti-coagulation factors in plasma from patients with cirrhosis Gastroenterology 137 2009 2105 2111
13. T. Lisman, K. Bakhtiari, I.T.A. Pereboom, H.G.D. Hendriks, J. Meijers, and R. Porte Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests J Hepatol 52 2010 355 361
14. T. Lisman, F.W. Leebeek, L.O. Mosnier, B.N. Bouma, J.C. Meijers, and H.L. Janssen Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis Gastroenterology 121 2001 131 139
15. C.K. Argo, and S.H. Caldwell Epidemiology and natural history of non-alcoholic steatohepatitis Clin Liver Dis 13 2009 511 531
16. G. Targher, L. Bertolini, L. Scala, G. Zoppini, L. Zenari, and G. Falezza Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue Diabet Med 22 2005 1354 1358
17. M. Cigolini, G. Targher, G. Agostino, M. Tonoli, M. Muggeo, and G. De Sandre Liver steatosis and its relation to plasma haemostatic factors in apparently healthy men - role of the metabolic syndrome Thromb Haemost 76 1996 69 73
18. N. Villanova, S. Moscatiello, S. Ramilli, E. Bugianesi, D. Magalotti, and E. Vanni Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease Hepatology 42 2005 473 480
19. A. Natarajan, A.G. Zaman, and S.M. Marshall Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents Diab Vasc Dis Res 5 2008 138 144
20. C.W. Kopp, H.P. Kopp, S. Steiner, S. Kriwanek, K. Krzyzanowska, and A. Bartok Weight loss reduces tissue factor in morbidly obese patients Obes Res 11 2003 950 956
21. S.J. Munoz, R.T. Stravitz, and D.A. Gabriel Coagulopathy of acute liver failure Clin Liver Dis 13 2009 95 107
22. R. Kerr, P. Newsome, L. Germain, E. Thomson, P. Dawson, and D. Stirling Effects of acute liver injury on blood coagulation J Thromb Haemost 1 2003 754 759
23. J.R. Pernambuco, P.G. Langley, R.D. Hughes, S. Izumi, and R. Williams Activation of the fibrinolytic system in patients with fulminant liver failure Hepatology 18 1993 1350 1356
24. N. Warnaar, T. Lisman, and R.J. Porte The two tales of coagulation in liver transplantation Curr Opin Organ Transplant 13 2008 298 303
25. T. Lisman, S.H. Caldwell, F.W.G. Leebeek, and R.J. Porte Hemostasis in chronic liver disease - Is chronic liver disease associated with a bleeding diathesis? J Thromb Haemost 4 2006 2059 2060
26. P.M. Mannucci Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? No J Thromb Haemost 4 2006 721 723
27. M.T. de Boer, I.Q. Molenaar, H.G. Hendriks, M.J. Slooff, and R.J. Porte Minimizing blood loss in liver transplantation: progress through research and evolution of techniques Dig Surg 22 2005 265 275
28. L. Massicotte, D. Beaulieu, L. Thibeault, J.D. Roy, D. Marleau, and R. Lapointe Coagulation defects do not predict blood product requirements during liver transplantation Transplantation 85 2008 956 962
29. L. Massicotte, S. Lenis, L. Thibeault, M.P. Sassine, R.F. Seal, and A. Roy Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations Liver Transplant 12 2006 117 123
30. B. Castaneda, W. Debernardi-Venon, J.C. Bandi, V. Andreu, S. Perez-Del-Pulgar, and E. Moitinho The role of portal pressure in the severity of bleeding in portal hypertensive rats Hepatology 31 2000 581 586
31. E.C. Vieira da Rocha, E.A. D'Amico, S.H. Caldwell, T.R. Flores da Rocha, Soares.E. Silva, and Dos. CS A prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation Clin Gastroenterol Hepatol 7 2009 988 993
32. P.S. Kamath, M. Lacerda, D.A. Ahlquist, M.A. McKusick, J.C. Andrews, and D.A. Nagorney Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis Gastroenterology 118 2000 905 911
33. J.B. Segal, and W.H. Dzik Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review Transfusion 45 2005 1413 1425
34. M. Sharma, C. Yong, D. Majure, C. Zellner, J.P. Roberts, and N.M. Bass Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation Am J Cardiol 103 2009 742 746
35. A. De Gottardi, T. Thevenot, L. Spahr, I. Morard, S. Bresson-Hadni, and F. Torres Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study Clin Gastroenterol Hepatol 7 2009 906 909
36. D.C. Rockey, S.H. Caldwell, Z.D. Goodman, R.C. Nelson, and A.D. Smith Liver biopsy Hepatology 49 2009 1017 1044
37. A.L. Boks, E.J. Brommer, S.W. Schalm, and H.H. Van Vliet Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage Hepatology 6 1986 79 86
38. A. Anantharaju, K. Mehta, A.L. Mindikoglu, and D.H. Van Thiel Use of activated recombinant human factor VII (rhFVIIa) for colonic polypectomies in patients with cirrhosis and coagulopathy Dig Dis Sci 48 2003 1414 1424
39. D.H. Park, M.H. Kim, S.K. Lee, S.S. Lee, J.S. Choi, and M.H. Song Endoscopic sphincterotomy vs. endoscopic papillary balloon dilation for choledocholithiasis in patients with liver cirrhosis and coagulopathy Gastrointest Endosc 60 2004 180 185
40. S. Sindet-Pedersen Haemostasis in oral surgery - the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system Dan Med Bull 38 1991 427 443
41. G. Auzinger, G.P. O'Callaghan, W. Bernal, E. Sizer, and J.A. Wendon Percutaneous tracheostomy in patients with severe liver disease and a high incidence of refractory coagulopathy: a prospective trial Crit Care 11 2007 R110
42. B. Agarwal, S. Shaw, M.S. Hari, A.K. Burroughs, and A. Davenport Continuous renal replacement therapy (CRRT) in patients with liver disease: is circuit life different? J Hepatol 51 2009 504 509
43. C.K. Argo, and R.A. Balogun Blood products, volume control, and renal support in the coagulopathy of liver disease Clin Liver Dis 13 2009 73 85
44. H. Gronbaek, S.P. Johnsen, P. Jepsen, M. Gislum, H. Vilstrup, and Tage.-Jensen.U. Liver BMC Gastroenterol 8 2008 16
45. R.T. Stravitz, A.H. Kramer, T. Davern, A.O. Shaikh, S.H. Caldwell, and R.L. Mehta Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group Crit Care Med 35 2007 2498 2508
46. A.I. Sharara, and D.C. Rockey Gastroesophageal variceal hemorrhage N Engl J Med 345 2001 669 681
47. F. Violi, R. Leo, S. Basili, D. Ferro, C. Cordova, and F. Balsano Association between prolonged bleeding time and gastrointestinal hemorrhage in 102 patients with liver cirrhosis: results of a retrospective study Haematologica 79 1994 61 65
48. F. Violi, D. Ferro, S. Basili, C. Quintarelli, M. Saliola, and C. Alessandri Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis Hepatology 15 1992 672 676
49. F. Tacke, K. Fiedler, and C. Trautwein A simple clinical score predicts high risk for upper gastrointestinal hemorrhages from varices in patients with chronic liver disease Scand J Gastroenterol 42 2007 374 382
50. S. Siringo, P.A. McCormick, P. Mistry, G. Kaye, N. McIntyre, and A.K. Burroughs Prognostic significance of the white nipple sign in variceal bleeding Gastrointest Endosc 37 1991 51 55
51. J. Morales, E. Moitinho, J.G. Abraldes, M. Fernandez, and J. Bosch Effects of the V1a vasopressin agonist F-180 on portal hypertension-related bleeding in portal hypertensive rats Hepatology 38 2003 1378 1383
52. B. Castaneda, J. Morales, R. Lionetti, E. Moitinho, V. Andreu, and S. Perez-Del-Pulgar Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats Hepatology 33 2001 821 825
53. A. Colomo, V. Hernanzez-Gea, P. Madoz, A. Carles, C. Alvarez-Urturi, and M. Poca Hymodynamic changes and transfusion strategies in cirrhotic patients with acute variceal bleeding Hepatology 50 2009 403Aa
54. J.L. Boyer, C. Chatterjee, F.L. Iber, and A.K. Basu Effect of plasma-volume expansion on portal hypertension N Engl J Med 275 1966 750 755
55. I.T.A. Pereboom, M.T. de Boer, E.B. Haagsma, H.G.D. Hendriks, T. Lisman, and R.J. Porte Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury Anesth Analg 108 2009 1083 1091
56. M.T. de Boer, M.C. Christensen, M. Asmussen, C.S. van der Hilst, H.G. Hendriks, and M.J. Slooff The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation Anesth Analg 106 2008 32 44
57. H.J. Alter, and H.G. Klein The hazards of blood transfusion in historical perspective Blood 112 2008 2617 2626
58. N.L. Shah, S.H. Caldwell, and C.L. Berg The role of anti-fibrinolytics, rFVIIa and other pro-coagulants: prophylactic versus rescue? Clin Liver Dis 13 2009 87 93
59. B.G. Gazzard, J.M. Henderson, and R. Williams Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy Gut 16 1975 617 620
60. S.J. Munoz, K. Rajender Reddy, and W. Lee The coagulopathy of acute liver failure and implications for intracranial pressure monitoring Neurocrit Care 9 2008 103 107
61. M. Borzio, F. Salerno, L. Piantoni, M. Cazzaniga, P. Angeli, and F. Bissoli Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study Dig Liver Dis 33 2001 41 48
62. J. Goulis, A. Armonis, D. Patch, C. Sabin, L. Greenslade, and A.K. Burroughs Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage Hepatology 27 1998 1207 1212
63. S. Vivas, M. Rodriguez, M.A. Palacio, A. Linares, J.L. Alonso, and L. Rodrigo Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding Dig Dis Sci 46 2001 2752 2757
64. T.N. Chau, Y.W. Chan, D. Patch, S. Tokunaga, L. Greenslade, and A.K. Burroughs Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding Gut 43 1998 267 271
65. P. Montalto, J. Vlachogiannakos, D.J. Cox, S. Pastacaldi, D. Patch, and A.K. Burroughs Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study J Hepatol 37 2002 463 470
66. M. Senzolo, J. Coppell, E. Cholongitas, A. Riddell, C.K. Triantos, and D. Perry The effects of glycosaminoglycans on coagulation: a thromboelastographic study Blood Coagul Fibrinolysis 18 2007 227 236
67. C.H. Jun, C.H. Park, W.S. Lee, Y.E. Joo, H.S. Kim, and S.K. Choi Antibiotic prophylaxis using third generation cephalosporins can reduce the risk of early rebleeding in the first acute gastroesophageal variceal hemorrhage: a prospective randomized study J Korean Med Sci 21 2006 883 890
68. M.C. Hou, H.C. Lin, T.T. Liu, B.I. Kuo, F.Y. Lee, and F.Y. Chang Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial Hepatology 39 2004 746 753
69. B. Rasaratnam, D. Kaye, G. Jennings, F. Dudley, and J. Chin-Dusting The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial Ann Intern Med 139 2003 186 193
70. D. Gulley, E. Teal, A. Suvannasankha, N. Chalasani, and S. Liangpunsakul Deep vein thrombosis and pulmonary embolism in cirrhosis patients Dig Dis Sci 53 2008 3012 3017
71. K.K. Sogaard, E. Horvath-Puho, H. Gronbaek, P. Jepsen, H. Vilstrup, and H.T. Sorensen Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study Am J Gastroenterol 104 2009 96 101
72. P.G. Northup, M.M. McMahon, A.P. Ruhl, S.E. Altschuler, A. Volk-Bednarz, and S.H. Caldwell Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism Am J Gastroenterol 101 2006 1524 1528
73. M.J. Garcia-Fuster, N. Abdilla, M.J. Fabia, C. Fernandez, V. Oliver, and M.J. Forner Venous thromboembolism and liver cirrhosis Rev Esp Enferm Dig 100 2008 259 262
74. N. Warnaar, I.Q. Molenaar, S.D. Colquhoun, M.J. Slooff, S. Sherwani, and A.M. de Wolf Intraoperative pulmonary embolism and intracardiac thrombosis complicating liver transplantation: a systematic review J Thromb Haemost 6 2008 297 302
75. M. Melato, E. Mucli, F. Poldrugo, M. Valente, F. Zanconati, and K. Okuda Stroke-cirrhosis relationship: an autopsy study in a heavy drinking population Ital J Gastroenterol 23 1991 211 214
76. W.L. Howell, and W.C. MANION The low incidence of myocardial infarction in patients with portal cirrhosis of the liver: A review of 639 cases of cirrhosis of the liver from 17, 731 autopsies Am Heart J 60 1960 341 344
77. G. Marchesini, M. Ronchi, G. Forlani, E. Bugianesi, G. Bianchi, and A. Fabbri Cardiovascular disease in cirrhosis - a point-prevalence study in relation to glucose tolerance Am J Gastroenterol 94 1999 655 662
78. K.A. Britton, J.M. Gaziano, H.D. Sesso, and L. Djousse Relation of alcohol consumption and coronary heart disease in hypertensive male physicians (from the Physicians' Health Study) Am J Cardiol 104 2009 932 935
79. E.B. Rimm, E.L. Giovannucci, W.C. Willett, G.A. Colditz, A. Ascherio, and B. Rosner Prospective study of alcohol consumption and risk of coronary disease in men Lancet 338 1991 464 468
80. A. Kadayifci, V. Tan, P.C. Ursell, R.B. Merriman, and N.M. Bass Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies J Hepatol 49 2008 595 599
81. E.A. Tsochatzis, M. Senzolo, G. Germani, A. Gatt, and A.K. Burroughs Systematic review: portal vein thrombosis in cirrhosis Aliment Pharmacol Ther 31 2010 366 374
82. C. Francoz, J. Belghiti, V. Vilgrain, D. Sommacale, V. Paradis, and B. Condat Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation Gut 54 2005 691 697
83. M.A. Zocco, E. Di Stasio, R. De Cristofaro, M. Novi, M.E. Ainora, and F. Ponziani Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development J Hepatol 51 2009 682 689
84. T. Nonami, I. Yokoyama, S. Iwatsuki, and T.E. Starzl The incidence of portal vein thrombosis at liver transplantation Hepatology 16 1992 1195 1198
85. M.J. Orloff, M.S. Orloff, S.L. Orloff, and B. Girard Portal vein thrombosis in cirrhosis with variceal hemorrhage J Gastrointest Surg 1 1997 123 130 [Discussion]
86. L. Amitrano, M.A. Guardascione, V. Brancaccio, M. Margaglione, F. Manguso, and L. Iannaccone Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis J Hepatol 40 2004 736 741
87. J.P. Duffy, J.C. Hong, D.G. Farmer, R.M. Ghobrial, H. Yersiz, and J.R. Hiatt Vascular complications of orthotopic liver transplantation: experience in more than 4, 200 patients J Am Coll Surg 208 2009 896 903
88. T. Lisman, and R.J. Porte Hepatic artery thrombosis after liver transplantation: more than just a surgical complication? Transplant Int 22 2009 162 164
89. I.R. Wanless, F. Wong, L.M. Blendis, P. Greig, E.J. Heathcote, and G. Levy Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension Hepatology 21 1995 1238 1247
90. P.J. MacPhee, V.J. Dindzans, L.S. Fung, and G.A. Levy Acute and chronic changes in the microcirculation of the liver in inbred strains of mice following infection with mouse hepatitis virus type 3 Hepatology 5 1985 649 660
91. S. Fiorucci, E. Antonelli, E. Distrutti, B. Severino, R. Fiorentina, and M. Baldoni PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation Hepatology 39 2004 365 375
92. C.J. Scotton, M.A. Krupiczojc, M. Konigshoff, P.F. Mercer, Y.C. Lee, and N. Kaminski Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury J Clin Invest 119 2009 2550 2563
93. V. Calvaruso, S. Maimone, A. Gatt, E. Tuddenham, M. Thursz, and M. Pinzani Coagulation and fibrosis in chronic liver disease Gut 57 2008 1722 1727
94. Q.M. Anstee, R.D. Goldin, M. Wright, A. Martinelli, R. Cox, and M.R. Thursz Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies J Thromb Haemost 6 2008 1336 1343
95. M. Wright, R. Goldin, S. Hellier, S. Knapp, A. Frodsham, and B. Hennig Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection Gut 52 2003 1206 1210
96. W. Abe, K. Ikejima, T. Lang, K. Okumura, N. Enomoto, and T. Kitamura Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat J Hepatol 46 2007 286 294
97. G. Anfossi, I. Russo, P. Massucco, L. Mattiello, G. Doronzo, and A. De Salve Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity Eur J Clin Invest 34 2004 482 489
98. G.V. Papatheodoridis, N. Chrysanthos, E. Cholongitas, E. Pavlou, G. Apergis, and D.G. Tiniakos Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease J Hepatol 51 2009 931 938
99. C.M. Sullivan, I.J. Hickman, S. Flight, C. Campbell, D.H. Crawford, and P.P. Masci Altered clot kinetics in patients with non-alcoholic fatty liver disease Ann Hepatol 8 2009 331 338
100. A.C. Westerkamp, T. Lisman, and R.J. Porte How to minimize blood loss during liver surgery in patients with cirrhosis HPB (Oxford) 11 2009 453 458
101. A. Tripodi, M. Primignani, V. Chantarangkul, M. Clerici, A. Dell'Era, and F. Fabris Thrombin generation in patients with cirrhosis: the role of platelets Hepatology 44 2006 440 445
102. W.I. Youssef, F. Salazar, S. Dasarathy, T. Beddow, and K.D. Mullen Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study Am J Gastroenterol 98 2003 1391 1394
103. D.E. Bernstein, L. Jeffers, E. Erhardtsen, K.R. Reddy, S. Glazer, and P. Squiban Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study Gastroenterology 113 1997 1930 1937
104. J.P. Lodge, S. Jonas, E. Oussoultzoglou, M. Malago, C. Jayr, and D. Cherqui Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial Anesthesiology 102 2005 269 275
105. J.P. Lodge, S. Jonas, R.M. Jones, M. Olausson, J. Mir-Pallardo, and S. Soefelt Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation Liver Transplant 11 2005 973 979
106. R.M. Planinsic, M.J. van der, G. Testa, L. Grande, A. Candela, and R.J. Porte Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease Liver Transplant 11 2005 895 900
107. J. Bosch, D. Thabut, A. Albillos, N. Carbonell, J. Spicak, and J. Massard Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial Hepatology 47 2008 1604 1614
108. K.A. O'Connell, J.J. Wood, R.P. Wise, J.N. Lozier, and M.M. Braun Thromboembolic adverse events after use of recombinant human coagulation factor VIIa JAMA 295 2006 293 298
109. G. Agnelli, P. Parise, M. Levi, B. Cosmi, and G.G. Nenci Effects of desmopressin on hemostasis in patients with liver cirrhosis Haemostasis 25 1995 241 247
110. A.K. Burroughs, K. Matthews, M. Qadiri, N. Thomas, P. Kernoff, and E. Tuddenham Desmopressin and bleeding time in patients with cirrhosis Br Med J (Clin Res Ed) 291 1985 1377 1381
111. R. de Franchis, P.G. Arcidiacono, L. Carpinelli, B. Andreoni, L. Cestari, and S. Brunati Randomized controlled trial of desmopressin plus terlipressin vs. terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: a multicenter, double-blind study. New Italian Endoscopic Club Hepatology 18 1993 1102 1107
112. E.G. Pivalizza, R.D. Warters, and R. Gebhard Desmopressin before liver transplantation Can J Anaesth 50 2003 748 749
113. A.Y. Wong, M.G. Irwin, T.W. Hui, S.K. Fung, S.T. Fan, and E.S. Ma Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy Can J Anaesth 50 2003 14 20
114. R.J. Porte, I.Q. Molenaar, B. Begliomini, T.H. Groenland, A. Januszkiewicz, and L. Lindgren Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group Lancet 355 2000 1303 1309
115. J.F. Boylan, J.R. Klinck, A.N. Sandler, R. Arellano, P.D. Greig, and H. Nierenberg Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation Anesthesiology 85 1996 1043 1048 (Pubitemid 26378289)
116. M. Kohler Thrombogenicity of prothrombin complex concentrates Thromb Res 95 1999 S13 S17
117. J.G. McHutchison, G. Dusheiko, M.L. Shiffman, M. Rodriguez-Torres, S. Sigal, and M. Bourliere Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C N Engl J Med 357 2007 2227 2236
118. M. Senzolo, M.T. Sartori, and T. Lisman Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy? HPB (Oxford) 11 2009 459 464
119. J.F. Trotter, J. Olson, J. Lefkowitz, A.D. Smith, R. Arjal, and J. Kenison Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory Am J Transplant 7 2007 1624 1628
120. T. Lisman, Y. van Leeuwen, J. Adelmeijer, I.T. Pereboom, E.B. Haagsma, and A.P. van den Berg Interlaboratory variability in assessment of the model of end-stage liver disease score Liver Int 28 2008 1344 1351
121. D.C. Valla Thrombosis and anticoagulation in liver disease Hepatology 47 2008 1384 1393
122. J. Bekker, S. Ploem, and K.P. de Jong Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors Am J Transplant 9 2009 746 757
123. F. Gunsar, N. Rolando, S. Pastacaldi, D. Patch, M.L. Raimondo, and B. Davidson Late hepatic artery thrombosis after orthotopic liver transplantation Liver Transplant 9 2003 605 611
124. T. Lisman, and R.J. Porte Antiplatelet medication after liver transplantation: does it affect outcome? Liver Transplant 13 2007 644 646
125. M. Vivarelli, B.G. La, A. Cucchetti, A. Lauro, G.M. Del, and M. Ravaioli Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? Liver Transplant 13 2007 651 654
126. E. Sieders, P.M. Peeters, E.M. TenVergert, K.P. de Jong, R.J. Porte, and J.H. Zwaveling Early vascular complications after pediatric liver transplantation Liver Transplant 6 2000 326 332
127. K. Fujita, Y. Nozaki, K. Wada, M. Yoneda, H. Endo, and H. Takahashi Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease Gut 57 2008 1583 1591